Page last updated: 2024-10-21

sk&f-38393 and Hypoxia

sk&f-38393 has been researched along with Hypoxia in 2 studies

2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393

Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Polak, MJ1
Kennedy, LA1
Drummond, WH1
Almaraz, L1
Pérez-García, MT1
González, C1

Other Studies

2 other studies available for sk&f-38393 and Hypoxia

ArticleYear
Manipulation of dopamine receptors alters hypoxic pulmonary vasoconstriction in isolated perfused rat lungs.
    Life sciences, 1992, Volume: 51, Issue:17

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agents;

1992
Presence of D1 receptors in the rabbit carotid body.
    Neuroscience letters, 1991, Nov-11, Volume: 132, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Blood Vessel

1991